Dr. Myall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2016 - 2019- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2012 - 2015
Stanford University School of MedicineClass of 2012
Certifications & Licensure
CA State Medical License 2013 - 2026
OR State Medical License 2021 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Afatinib and Necitumumab in-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors.Nathaniel J Myall, Jennifer G Whisenant, Joel W Neal, Wade T Iams, Karen L Reckamp
JTO Clinical and Research Reports. 2025-02-01 - 1 citationsROS1-rearranged non-small cell lung cancer: Understanding biology and optimizing management in the era of new approvals.Nathaniel J Myall, Millie Das
Current Problems in Cancer. 2024-12-01 - 2 citationsTyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases FromandOncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC).Luke R G Pike, Emily Miao, Lillian A Boe, Tejas Patil, Brandon S Imber
Journal of Clinical Oncology. 2024-10-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
